Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children (EFUJA)
Primary Purpose
Uropathy, Kidney Transplantation
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
magnetic-end Double-J ureteral stent
Sponsored by
About this trial
This is an interventional other trial for Uropathy focused on measuring Double-J ureteral stent (DJUS), magnetic-end, Pediatric urology, Uropathy, Kidney graft
Eligibility Criteria
Inclusion Criteria:
- Child aged between 0 and 17 years and 10 months at the surgery
- Child operated at the Necker hospital for an uropathy or kidney graft need the insertion of JJ ureteral stent
- Parents or legal guardians signed the Informed consent form
- Social insurance affiliation
Exclusion Criteria:
- All clinical situation need an MRI
- Contraindication with the experimental medical device (severe infections, obstruction, …)
For the medico-economic study, a comparative group will be constituted with patients treated with classic ureteral stent in the Necker hospital in the previous years.
This group will be matched with age (<5 years, 5-12 years and >13years), sex and surgery indication (kidney graft or other).
Sites / Locations
- Hôpital NeckerRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Double-J ureteral stent
Arm Description
Pediatric patient with an uropathy or kidney graft need the insertion of Double-J ureteral stent in a routine care
Outcomes
Primary Outcome Measures
Successful remove of the Double-J ureteral stent with magnet
A successful remove is a remove of the Double-J (JJ) ureteral stent with the magnet removal system, without general anaesthesia - The measure is a binary criterion: success/ failure, evaluated by the surgeon
Secondary Outcome Measures
Successful insertion of the Double-J ureteral stent with magnet
A successful insertion is an insertion of the JJ ureteral stent with magnet in retrograde, antegrade process or open surgery - The measure is a binary criterion: success/ failure, evaluated by the surgeon
Duration of hospitalization
Number of total days of hospitalization
Costs of hospitalization after surgery
Costs of hospitalization after surgery
Full Information
NCT ID
NCT04384939
First Posted
February 20, 2020
Last Updated
October 28, 2022
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT04384939
Brief Title
Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children
Acronym
EFUJA
Official Title
Feasibility, Safety and Medico-economic Study of Magnetic-end Double-J Ureteral Stent Use in Children
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 9, 2021 (Actual)
Primary Completion Date
January 2023 (Anticipated)
Study Completion Date
February 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Double-J ureteral stent (DJUS) is one of the most common devices used in urology. Ureteral stenting has a wide spectrum of indications that can be summarized in two words: obstruction and leakage. Common indications in pediatric urology are pyeloplasty, ureteral reimplantation, kidney transplantation and stone disease.
Classically, DJUS are introduced and removed in the operation room, under general anesthesia, using a cystoscope.
The magnetic-end Double-J ureteral stent is a 4.8 French DJUS with a small magnet fixed with a string at the distal loop.
To remove the magnetic stent, a 9 French customized catheter-like retrieval device with a magnetic Tiemann tip is inserted into the urethra in the outpatient clinic.
The purpose of this study is to demonstrate the feasibility and safety of magnetic-end Double-J ureteral stent use in children and to perform a medico-economic study.
Detailed Description
First reported in 1967, ureteral stenting evolved fast until the introduction of the double-J ureteral stent (DJUS) in 1978. It has since become one of the most common devices used in urology. Ureteral stenting has a wide spectrum of indications that can be summarized in two words: obstruction and leakage. Common indications in pediatric urology are pyeloplasty, ureteral reimplantation, kidney transplantation and stone disease.
Many modifications have been introduced to Finney's double-J to reduce stent-related complications and disadvantages, one of which is its removal technique. Classically, DJUS are introduced and removed in the operation room (OR), under general anesthesia (GA), using a cystoscope. Efforts have been made to avoid the second procedure under GA. Preventing the patient from undergoing a second OR experience is not the only issue. For institutions, DJUS removal is time consuming and costly in terms of resources, OR occupancy, and staff. In children, the potential neurotoxicity of repeated exposures to GA, is also a major concern.
Alternatives to surgical removal of DJUS vary from basic solutions such as transurethral string, hook, or other tools, to more complex innovations such as the single use flexible cystoscope, and biodegradable stents. Moreover, some pediatric teams used the externalized pyeloureteral stent as an alternative to DJUS. Using magnet for ureteral stent retrieval was introduced in the early 80s. Difficulties related to its insertion, as well as its low retrieval success rate, minimized its acceptance. It wasn't until 2002 when Taylor and McDougall revisited the concept of magnetic retrieval of the ureteral stent. Since then, few teams have published their experience with magnetic-end DJUS.
The magnetic-end Double-J ureteral stent is a 4.8 French DJUS with a small magnet fixed with a string at the distal loop. Explanation of the retrieval method and its potential complications are given to the parents, and informed consent obtained prior to surgery. All of the stents are inserted under GA in the exact same manner as regular DJUS: antegrade, retrograde (cystoscopy insertion) or open surgery. The stent's length varies between 12 and 24 cm depending on the age and weight of the child. An abdominal plain X-Ray is routinely done after pyeloplasty to check the position of the DJUS distal loop (MEDJUS or not) in the bladder before waking up the child. A successful stent insertion is defined as having a good position of the distal end and its magnet in the bladder
To remove the magnetic-end Double-J ureteral stent, a 9 French customized catheter-like retrieval device with a magnetic Tiemann tip, lubricated with 2% lidocaine jelly, is inserted into the urethra by the surgeon with the patient breathing inhaled premixed nitrous oxide and oxygen for procedural sedation in the outpatient clinic. Both indwelling magnets connect and the catheter can be removed together with the MEDJUS. Success of magnetic retrieval are regarded as MEDJUS retrieval in outpatient clinic with no need of general anesthesia.
The aim is to demonstrate the feasibility and safety of the magnetic-end DJUS in children and perform a medico-economic study / cost-effectiveness study to evaluate the impact of the use of MEDJUS in children in terms of retrieval time and cost, as well as OR and staff occupancy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uropathy, Kidney Transplantation
Keywords
Double-J ureteral stent (DJUS), magnetic-end, Pediatric urology, Uropathy, Kidney graft
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
67 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Double-J ureteral stent
Arm Type
Experimental
Arm Description
Pediatric patient with an uropathy or kidney graft need the insertion of Double-J ureteral stent in a routine care
Intervention Type
Device
Intervention Name(s)
magnetic-end Double-J ureteral stent
Other Intervention Name(s)
No applied
Intervention Description
Inserting the ureteral stent with magnet (same process as classic ureteral stent)
Removing the ureteral stent with magnet without general anaesthesia. Usually, the classic ureteral stent removed during a general anaesthesia.
Primary Outcome Measure Information:
Title
Successful remove of the Double-J ureteral stent with magnet
Description
A successful remove is a remove of the Double-J (JJ) ureteral stent with the magnet removal system, without general anaesthesia - The measure is a binary criterion: success/ failure, evaluated by the surgeon
Time Frame
During the stent removal consultation, usually between 8 and 30 days after the surgery
Secondary Outcome Measure Information:
Title
Successful insertion of the Double-J ureteral stent with magnet
Description
A successful insertion is an insertion of the JJ ureteral stent with magnet in retrograde, antegrade process or open surgery - The measure is a binary criterion: success/ failure, evaluated by the surgeon
Time Frame
1 day
Title
Duration of hospitalization
Description
Number of total days of hospitalization
Time Frame
At the end of the initial hospitalisation, at maximum 60 days
Title
Costs of hospitalization after surgery
Description
Costs of hospitalization after surgery
Time Frame
Until the stent removal consultation, usually between 8 and 30 days after the surgery
10. Eligibility
Sex
All
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Child aged between 0 and 17 years and 10 months at the surgery
Child operated at the Necker hospital for an uropathy or kidney graft need the insertion of JJ ureteral stent
Parents or legal guardians signed the Informed consent form
Social insurance affiliation
Exclusion Criteria:
All clinical situation need an MRI
Contraindication with the experimental medical device (severe infections, obstruction, …)
For the medico-economic study, a comparative group will be constituted with patients treated with classic ureteral stent in the Necker hospital in the previous years.
This group will be matched with age (<5 years, 5-12 years and >13years), sex and surgery indication (kidney graft or other).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas BLANC, MD, PhD
Phone
+33-1 44 49 51 43
Email
thomas.blanc@aphp.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Sandra COLAS
Phone
+33-1 71 19 64 32
Email
sandra.colas@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas BLANC, MD, PhD
Organizational Affiliation
Assistance Publique -Hôpitaux de Paris (AP-HP)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Necker
City
Paris
ZIP/Postal Code
75015
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas BLANC, MD PhD
Phone
+33-1 44 49 51 43
Email
thomas.blanc@aphp.fr
12. IPD Sharing Statement
Learn more about this trial
Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children
We'll reach out to this number within 24 hrs